|
|
|
|
||
Re: Global Blood Therapeutics Announces Pivotal Study For GBT440 In Sickle Cell Disease With Primary Hemoglobin EndpointLOL. My bad! I saw the October date and I guess in my mind the 6 morphed into an 8. My apologies. |
return to message board, top of board |